Operating income increased 14.4%
Operating income changed +14.4% from the comparable as-filed period.
$54.6M→$62.4M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →BCPC financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 108 bp higher
Operating margin changed +108 basis points from the comparable as-filed period.
20.40%→21.48%2 prior comparisons
Inventory / revenue moved 1140 bp higher
Inventory / revenue changed +1140 basis points from the comparable as-filed period.
49.50%→60.90%2 prior comparisons
Working capital increased 10.8%
Working capital changed +10.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$217.3M→$240.8M4 prior comparisons
Revenue increased 8.6%
Revenue changed +8.6% from the comparable as-filed period.
$267.6M→$290.7M2 prior comparisons
Gross margin moved 69 bp higher
Gross margin changed +69 basis points from the comparable as-filed period.
35.68%→36.37%2 prior comparisons
Total assets increased 2.6%
Total assets changed +2.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$1.7B→$1.7B4 prior comparisons
Research & development increased 18.8%
Research & development changed +18.8% from the comparable as-filed period.
$4.5M→$5.3M2 prior comparisons
Working capital / assets moved 105 bp higher
Working capital / assets changed +105 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
13.09%→14.13%4 prior comparisons
Operating cash flow increased 6.4%
Operating cash flow changed +6.4% from the comparable as-filed period.
$65.6M→$69.8M2 prior comparisons
Gross profit increased 10.7%
Gross profit changed +10.7% from the comparable as-filed period.
$95.5M→$105.7M2 prior comparisons
Trade receivables increased 10.7%
Trade receivables changed +10.7% from the comparable as-filed period.
$131.5M→$145.6M3 prior comparisons
Cost of revenue increased 7.5%
Cost of revenue changed +7.5% from the comparable as-filed period.
$172.1M→$184.9M2 prior comparisons
Stock-based compensation increased 8.4%
Stock-based compensation changed +8.4% from the comparable as-filed period.
$4.7M→$5.0M2 prior comparisons
Receivables / revenue moved 94 bp higher
Receivables / revenue changed +94 basis points from the comparable as-filed period.
49.16%→50.11%2 prior comparisons
SBC / revenue moved 0 bp lower
SBC / revenue changed -0 basis points from the comparable as-filed period.
1.74%→1.73%2 prior comparisons
R&D / revenue moved 16 bp higher
R&D / revenue changed +16 basis points from the comparable as-filed period.
1.68%→1.84%2 prior comparisons
Cash & equivalents increased 1.8%
Cash & equivalents changed +1.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$65.1M→$66.3M4 prior comparisons
Operating cash-flow margin moved 50 bp lower
Operating cash-flow margin changed -50 basis points from the comparable as-filed period.
24.51%→24.00%2 prior comparisons
Revenue increased 11.2%
Revenue changed +11.2% from the comparable as-filed period.
$255.5M→$284.0M2 prior comparisons
Operating margin moved 72 bp higher
Operating margin changed +72 basis points from the comparable as-filed period.
20.14%→20.85%2 prior comparisons
Gross margin moved 6 bp higher
Gross margin changed +6 basis points from the comparable as-filed period.
36.45%→36.51%2 prior comparisons
Operating cash flow decreased 1.1%
Operating cash flow changed -1.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$47.3M→$46.7M3 prior comparisons
Inventory / revenue moved 111 bp lower
Inventory / revenue changed -111 basis points from the comparable as-filed period.
57.99%→56.88%2 prior comparisons
Gross profit increased 11.4%
Gross profit changed +11.4% from the comparable as-filed period.
$93.1M→$103.7M2 prior comparisons
Cost of revenue increased 11.1%
Cost of revenue changed +11.1% from the comparable as-filed period.
$162.4M→$180.3M2 prior comparisons
Working capital increased 7.0%
Working capital changed +7.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$226.7M→$242.7M4 prior comparisons
Current assets increased 6.5%
Current assets changed +6.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$364.9M→$388.4M4 prior comparisons
Operating cash-flow margin moved 205 bp lower
Operating cash-flow margin changed -205 basis points from the comparable as-filed period.
18.50%→16.45%2 prior comparisons
Trade receivables increased 9.6%
Trade receivables changed +9.6% from the comparable as-filed period.
$136.0M→$149.0M3 prior comparisons
Inventory increased 9.0%
Inventory changed +9.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$148.2M→$161.6M4 prior comparisons
Research & development increased 5.4%
Research & development changed +5.4% from the comparable as-filed period.
$4.3M→$4.5M2 prior comparisons
Cash & equivalents decreased 3.4%
Cash & equivalents changed -3.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$65.4M→$63.2M4 prior comparisons
Current liabilities increased 5.5%
Current liabilities changed +5.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$138.1M→$145.8M4 prior comparisons
Working capital / assets moved 88 bp higher
Working capital / assets changed +88 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
13.51%→14.38%4 prior comparisons
SBC / revenue moved 20 bp lower
SBC / revenue changed -20 basis points from the comparable as-filed period.
2.29%→2.08%2 prior comparisons
Total assets increased 0.5%
Total assets changed +0.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.7B→$1.7B4 prior comparisons
R&D / revenue moved 9 bp lower
R&D / revenue changed -9 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.68%→1.60%2 prior comparisons
Receivables / revenue moved 77 bp lower
Receivables / revenue changed -77 basis points from the comparable as-filed period.
53.23%→52.46%2 prior comparisons
Stock-based compensation increased 1.4%
Stock-based compensation changed +1.4% from the comparable as-filed period.
$5.8M→$5.9M3 prior comparisons
Current ratio increased 0.9%
Current ratio changed +0.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
2.64→2.664 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.